Parenteral Drug Association
Acronym: PDA
General Information
Identification Code: 894106921549-04
Website: [object Object]
Entity Form: Not for profit legal association
Registration Category: Non-governmental organisations, platforms and networks and similar
Registration Date: 4/26/2016
Last Update: 2/14/2024
EP Accredited Number: 0
Mission & Interests
Goals: The Parenteral Drug Association (PDA) is the leading global facilitator of science, technology and regulatory information. The PDA creates awareness and understanding of important issues facing the pharmaceutical and biopharmaceutical community and delivers education for the community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and expertise to advance pharmaceutical / biopharmaceutical manufacturing science and regulation so members can better serve patients. PDA is the recognized authoritative voice and leading technical organization in the field of parenteral science and technology. Through the development of Technical Reports and responses to regulatory initiatives, PDA and its members influence the future course of pharmaceutical products technology.
MISSION: To advance pharmaceutical / biopharmaceutical manufacturing science and regulation so members can better serve patients.
Interests Represented: Does not represent commercial interests
Interests:
- Public health
- Research and innovation
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: Directive 2001/83/EC and related EMA scientific guidelines
Rules Governing Medicinal Products in the EU (Eudralex) Volumes 1,4,5 (medicinal products, veterinary products, good manufacturing practices), including Annexes
CHMP Quality Guidelines
Directive 2001/62/EU (Falsified Medicines)
Regulation(EC) No 1394/2007 (Advanced Therapies)
Communication Activities: PDA follows and responds to the publications of EMA, EDQM, DG Sante, National Health Authorities, and PIC/S in areas related to pharmaceutical manufacturing such as: Advanced Therapies, Active Pharmaceutical Ingredients, Aseptic Processing, Drug Shortages, Data Integrity, Good Manufacturing Practices, Medicinal Products, Microbiology, Sterilisation and Visual Inspection.
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 4350 East West HighwaySuite 600
Post Code: 20814
City: Bethesda
Country: UNITED STATES
Phone: [object Object]
EU Office
Address: Am Borsigturm 60
Post Code: 13507
City: Berlin
Country: GERMANY
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Membership Information
Members10 Percent: 0
Members25 Percent: 8
Members50 Percent: 0
Members75 Percent: 0
Members: 8
Members F T E: 2
Info Members: The number above includes both paid staff and volunteer members who represent PDA in interactions with EU institutions or work to develop technical documents that are shared in meetings with EU institutions or submitted through public commenting processes. In general a wide array of members each spend a small amount of their time on a variety of global topics.
Staff in both the PDA Science and Regulatory Department and European Headquarters support more than 10,000 individual members worldwide. PDA draws its strength from the technical expertise of its membership. Conferences, meetings and courses bring together employees of pharmaceutical manufacturers, suppliers, users, academics and regulatory officials to discuss issues of mutual interest and develop scientific responses to health authority publications. These exchanges of technical knowledge and expertise assist the advancement of pharmaceutical science and technology in the interest of public health and safety.
Structure
Structure Type: Structure
Is Member Of: PDA does not have organizational members. Membership is retained by individuals.
Organisation Members: RX 360 http://rx-360.org/en-us/
Product Quality Research Institute http://pqri.org/
Partnership for Safe Medicines
United States Pharmacopeia http://www.usp.org